Search

everythinglearnresearchcommunity

for

Search:↓

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

There are many treatments for permanent hair loss disorders, but their effectiveness varies and there's no clear best option.

Trichoscopy helps diagnose and monitor alopecia areata by looking at a combination of specific hair and scalp features.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Black dots under trichoscopy can appear in different hair and scalp conditions, not just in alopecia areata.

Perifollicular erythema can indicate active frontal fibrosing alopecia.

Lack of small, fine hair on the front hairline is a key sign of frontal fibrosing alopecia.

Hair thickness differences help diagnose hair loss severity.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Trichoscopy is reliable for diagnosing Temporal Triangular Alopecia and can prevent unnecessary biopsies and wrong treatments.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

The document concludes that new methods improve the accuracy of diagnosing scalp alopecia and challenges the old way of classifying it.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

Taking oral isotretinoin with creams worked better for treating a type of hair loss than creams alone.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

Frontal Fibrosing Alopecia might be an autoimmune disease.

A man had temporary hair loss from radiation during a medical procedure but regrew his hair after treatment with minoxidil lotion.

In Spain, dermatologists most commonly prescribe topical minoxidil and oral finasteride for male hair loss, and topical minoxidil and oral contraceptives for female hair loss. The use of oral dutasteride and oral minoxidil has significantly increased over the past three years.

A possible link exists between minimal change nephrotic syndrome and complete hair loss.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

Hydroxychloroquine is most effective for scarring alopecias, especially when combined with other treatments.

Lupus patients in Ghana face healthcare challenges, and the Oyemam Autoimmune Foundation is working to improve awareness and support.

Androgenetic alopecia is the most common type of non-scarring hair loss, especially in young males, and early diagnosis and treatment are important.

Trichoscopy helps diagnose scarring alopecia early and non-invasively.